beta-Carotene inhibits the oxidative modification of low-density lipoprotein

Biochim Biophys Acta. 1991 Oct 15;1086(1):134-8. doi: 10.1016/0005-2760(91)90164-d.

Abstract

Several lines of evidence indicate that oxidized LDL (Ox-LDL) may promote atherogenesis. Hence, the role of antioxidants in the prevention of LDL oxidation needs to be determined. beta-Carotene, in addition to being an efficient quencher of singlet oxygen, can also function as a radical-trapping antioxidant. Since previous studies have failed to show that beta-carotene inhibits LDL oxidation, we re-examined its effect on the oxidative modification of LDL. For these studies, LDL was oxidized in both a cell-free (2.5 microM Cu2+ in PBS) and a cellular system (human monocyte macrophages in Ham's F-10 medium). beta-Carotene inhibited the oxidative modification of LDL in both systems as evidenced by a decrease in the lipid peroxide content (thiobarbituric-acid-reacting substances activity), the negative charge of LDL (electrophoretic mobility) and the formation of conjugated dienes. By inhibiting LDL oxidation, beta-carotene substantially decreased its degradation by macrophages. beta-Carotene (2 microM) was more potent than alpha-tocopherol (40 microM) in inhibiting LDL oxidation. Thus, beta-carotene, like ascorbate and alpha-tocopherol, inhibits LDL oxidation and might have an important role in the prevention of atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antioxidants / pharmacology*
  • Carotenoids / pharmacology*
  • Cell-Free System
  • Humans
  • In Vitro Techniques
  • Lipoproteins, LDL / drug effects*
  • Lipoproteins, LDL / metabolism
  • Macrophages / metabolism
  • Oxidation-Reduction / drug effects
  • beta Carotene

Substances

  • Antioxidants
  • Lipoproteins, LDL
  • beta Carotene
  • Carotenoids